Opioid Induced Constipation Drugs Market Report

Global and Europe Opioid Induced Constipation Drugs Market Professional Survey Report 2019

  • POSTDATE：May 27, 2020
  • PAGES：151
  • REPORT CODE：GMM532139
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Opioid Induced Constipation Drugs market was valued at XX.0 million US$ in 2018, with the CAGR of 4.5%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Opioid Induced Constipation Drugs market. Describe product range of Opioid Induced Constipation Drugs, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Opioid Induced Constipation Drugs market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Opioid Induced Constipation Drugs market.

     

    By Player

    • Cosmo Pharmaceuticals SA

    • Daiichi Sankyo Co Ltd

    • Ironwood Pharmaceuticals Inc

    • Sucampo Pharmaceuticals

    • Valeant Pharmaceuticals International

    • Theravance Biopharma Inc

    • Purdue Pharma

    • Allergan Plc

    • Pfizer

    • Daewoong Pharmaceutical

    • Mundipharma International Limited

    • Nektar Therapeutics

    • Takeda Pharmaceutical Company Limited

    • Progenics Pharmaceuticals Inc

    By Type

    • Lubiprostone

    • Methyl Naltrexone Bromide

    • Naldemedine

    • Alvimopan

    • Others

    By End-User

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioid Induced Constipation Drugs Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Lubiprostone from 2014 to 2026

      • 1.3.2 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide from 2014 to 2026

      • 1.3.3 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Naldemedine from 2014 to 2026

      • 1.3.4 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Alvimopan from 2014 to 2026

      • 1.3.5 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

      • 1.4.2 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

      • 1.4.3 Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Opioid Induced Constipation Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Opioid Induced Constipation Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Opioid Induced Constipation Drugs by Major Types

      • 3.4.1 Opioid Induced Constipation Drugs Market Size and Growth Rate of Lubiprostone

      • 3.4.2 Opioid Induced Constipation Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide

      • 3.4.3 Opioid Induced Constipation Drugs Market Size and Growth Rate of Naldemedine

      • 3.4.4 Opioid Induced Constipation Drugs Market Size and Growth Rate of Alvimopan

      • 3.4.5 Opioid Induced Constipation Drugs Market Size and Growth Rate of Others

    4 Segmentation of Opioid Induced Constipation Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Opioid Induced Constipation Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Opioid Induced Constipation Drugs for Hospital Pharmacies

      • 4.4.2 Market Size and Growth Rate of Opioid Induced Constipation Drugs for Retail Pharmacies

      • 4.4.3 Market Size and Growth Rate of Opioid Induced Constipation Drugs for Online Pharmacies

    5 Market Analysis by Major Regions

    • 5.1 Global Opioid Induced Constipation Drugs Production Analysis by Top Regions

    • 5.2 Global Opioid Induced Constipation Drugs Consumption Analysis by Top Regions

    • 5.3 Global Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Opioid Induced Constipation Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Opioid Induced Constipation Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Opioid Induced Constipation Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Opioid Induced Constipation Drugs Landscape Analysis

    • 7.1 North America Opioid Induced Constipation Drugs Landscape Analysis by Top Countries

      • 7.1.1 United States Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 7.1.2 Canada Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 7.1.3 Mexico Opioid Induced Constipation Drugs Market Volume and Growth Rate

    8. Europe Opioid Induced Constipation Drugs Landscape Analysis

    • 8.1 Europe Opioid Induced Constipation Drugs Landscape Analysis by Major Types

    • 8.2 Europe Opioid Induced Constipation Drugs Landscape Analysis by Major End-Users

    • 8.3 Europe Opioid Induced Constipation Drugs Landscape Analysis by Top Countries

      • 8.3.1 Germany Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.2 UK Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.3 France Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.4 Italy Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.5 Spain Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.6 Belgium Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.7 Poland Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.8 Russia Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.9 Turkey Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.10 Netherlands Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.11 Portugal Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.12 Denmark Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.13 Finland Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.14 Iceland Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.15 Norway Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 8.3.16 Sweden Opioid Induced Constipation Drugs Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Opioid Induced Constipation Drugs Landscape Analysis

    • 9.1 Asia Pacific Opioid Induced Constipation Drugs Landscape Analysis by Top Countries

      • 9.1.1 China Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 9.1.2 Japan Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 9.1.4 India Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 9.1.5 ASEAN Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 9.1.6 South Korea Opioid Induced Constipation Drugs Market Volume and Growth Rate

    10 LAMEA Opioid Induced Constipation Drugs Landscape Analysis

    • 10.1 LAMEA Opioid Induced Constipation Drugs Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 10.1.2 Brazil Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 10.1.3 North Africa Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 10.1.4 South Africa Opioid Induced Constipation Drugs Market Volume and Growth Rate

      • 10.1.5 Argentina Opioid Induced Constipation Drugs Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Cosmo Pharmaceuticals SA

      • 11.1.1 Cosmo Pharmaceuticals SA Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Daiichi Sankyo Co Ltd

      • 11.2.1 Daiichi Sankyo Co Ltd Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Ironwood Pharmaceuticals Inc

      • 11.3.1 Ironwood Pharmaceuticals Inc Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Sucampo Pharmaceuticals

      • 11.4.1 Sucampo Pharmaceuticals Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Valeant Pharmaceuticals International

      • 11.5.1 Valeant Pharmaceuticals International Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Theravance Biopharma Inc

      • 11.6.1 Theravance Biopharma Inc Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Purdue Pharma

      • 11.7.1 Purdue Pharma Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Allergan Plc

      • 11.8.1 Allergan Plc Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Pfizer

      • 11.9.1 Pfizer Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Daewoong Pharmaceutical

      • 11.10.1 Daewoong Pharmaceutical Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Mundipharma International Limited

      • 11.11.1 Mundipharma International Limited Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Nektar Therapeutics

      • 11.12.1 Nektar Therapeutics Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Takeda Pharmaceutical Company Limited

      • 11.13.1 Takeda Pharmaceutical Company Limited Company Profile and Development Status

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Progenics Pharmaceuticals Inc

      • 11.14.1 Progenics Pharmaceuticals Inc Company Profile and Development Status

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 115 Figures and 166 Tables)

    • Figure Product Picture

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Lubiprostone from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Methyl Naltrexone Bromide from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Naldemedine from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Alvimopan from 2014 to 2026

    • Figure Opioid Induced Constipation Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Global Opioid Induced Constipation Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Figure North America Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure United States Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure China Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure India Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Opioid Induced Constipation Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Opioid Induced Constipation Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Opioid Induced Constipation Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Opioid Induced Constipation Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Opioid Induced Constipation Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Lubiprostone

    • Figure Market Size and Growth Rate of Methyl Naltrexone Bromide

    • Figure Market Size and Growth Rate of Naldemedine

    • Figure Market Size and Growth Rate of Alvimopan

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Opioid Induced Constipation Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Opioid Induced Constipation Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Table Global Opioid Induced Constipation Drugs Production by Major Regions

    • Table Global Opioid Induced Constipation Drugs Production Share by Major Regions

    • Table Global Opioid Induced Constipation Drugs Consumption by Major Regions

    • Table Global Opioid Induced Constipation Drugs Consumption Share by Major Regions

    • Table North America Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Europe Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table LAMEA Opioid Induced Constipation Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Opioid Induced Constipation Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Opioid Induced Constipation Drugs Consumption by Major Countries from 2014 to 2026

    • Table North America Opioid Induced Constipation Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2014

    • Figure North America Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2018

    • Figure North America Opioid Induced Constipation Drugs Consumption Share by Major Countries in 2026

    • Figure United States Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Opioid Induced Constipation Drugs Consumption by Types from 2014 to 2026

    • Table Europe Opioid Induced Constipation Drugs Consumption Share by Types from 2014 to 2026

    • Table Europe Opioid Induced Constipation Drugs Consumption by End-Users from 2014 to 2026

    • Table Europe Opioid Induced Constipation Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Europe Opioid Induced Constipation Drugs Consumption by Major Countries from 2014 to 2026

    • Table Europe Opioid Induced Constipation Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure France Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Opioid Induced Constipation Drugs Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Opioid Induced Constipation Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure China Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure India Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Opioid Induced Constipation Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Opioid Induced Constipation Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Cosmo Pharmaceuticals SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cosmo Pharmaceuticals SA

    • Figure Sales and Growth Rate Analysis of Cosmo Pharmaceuticals SA

    • Figure Revenue and Market Share Analysis of Cosmo Pharmaceuticals SA

    • Table Product and Service Introduction of Cosmo Pharmaceuticals SA

    • Table Company Profile and Development Status of Daiichi Sankyo Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo Co Ltd

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo Co Ltd

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo Co Ltd

    • Table Product and Service Introduction of Daiichi Sankyo Co Ltd

    • Table Company Profile and Development Status of Ironwood Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals Inc

    • Table Product and Service Introduction of Ironwood Pharmaceuticals Inc

    • Table Company Profile and Development Status of Sucampo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sucampo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sucampo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sucampo Pharmaceuticals

    • Table Product and Service Introduction of Sucampo Pharmaceuticals

    • Table Company Profile and Development Status of Valeant Pharmaceuticals International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International

    • Table Product and Service Introduction of Valeant Pharmaceuticals International

    • Table Company Profile and Development Status of Theravance Biopharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Theravance Biopharma Inc

    • Figure Sales and Growth Rate Analysis of Theravance Biopharma Inc

    • Figure Revenue and Market Share Analysis of Theravance Biopharma Inc

    • Table Product and Service Introduction of Theravance Biopharma Inc

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of Allergan Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan Plc

    • Figure Sales and Growth Rate Analysis of Allergan Plc

    • Figure Revenue and Market Share Analysis of Allergan Plc

    • Table Product and Service Introduction of Allergan Plc

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Daewoong Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daewoong Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Daewoong Pharmaceutical

    • Figure Revenue and Market Share Analysis of Daewoong Pharmaceutical

    • Table Product and Service Introduction of Daewoong Pharmaceutical

    • Table Company Profile and Development Status of Mundipharma International Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mundipharma International Limited

    • Figure Sales and Growth Rate Analysis of Mundipharma International Limited

    • Figure Revenue and Market Share Analysis of Mundipharma International Limited

    • Table Product and Service Introduction of Mundipharma International Limited

    • Table Company Profile and Development Status of Nektar Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nektar Therapeutics

    • Figure Sales and Growth Rate Analysis of Nektar Therapeutics

    • Figure Revenue and Market Share Analysis of Nektar Therapeutics

    • Table Product and Service Introduction of Nektar Therapeutics

    • Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited

    • Table Product and Service Introduction of Takeda Pharmaceutical Company Limited

    • Table Company Profile and Development Status of Progenics Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals Inc

    • Table Product and Service Introduction of Progenics Pharmaceuticals Inc

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US